This week respected Houston based neurologist Dr. Steven Goldstein will discuss the price’s patients are charged by doctors and hospitals. Specifically, on the new rules about healthcare price transparency. Be sure to visit www.houstonhealthcareinitiative.org for more information about this and other issues.
A healthcare company blessed with lots of money, high tech abilities and really smart people will close up the end of January. Of course, this was Haven, the joint venture between Amazon, Berkshire Hathaway and JPMorgan-Chase. Its purpose was to use the leverage of its tens of thousands of employees and its expertise in technology to improve the healthcare system. What lessons can we learn from its failure to accomplish its mission. Here to help reset the focus of reforming healthcare is respected Houston neurologist, Dr. Steven Goldstein.
Dr. Steven Goldstein tells us all about how some very large organizations tried and failed at reforming their employee health insurance. This is a story about an organization that was called Haven. When it was formed, the three companies had a lofty goal: to provide U.S. employees and their families with simplified, high-quality, and transparent health care at a reasonable cost. Haven made one very big mistake, trying to fix the wrong thing. Learn more at www.houstonhealthcareinitiative.org.
That times are unsettled was never truer than in 2020 and 2021 will start out that way. But in an unsettled time with so much of the nation’s attention turned to medical care, could it be the time to really push healthcare reform and what might that reform look like? Americans remain in the midst of the Covid-19 pandemic. What can we learn from it and how can this influence our thinking when it comes to healthcare reform? Or is it all too big for any of us to do anything meaningful? Here to share his insight with us is respected neurologist and founder of the Houston Healthcare Initiative, Dr. Steven Goldstein. Visit www.houstonhealthcareinitiative.org for more.
Is it possible to get good health insurance coverage in 2021 and save money on treatments, prescription drugs and the policy too? The answer according to Dr. Steven Goldstein, founder of the Houston Healthcare Initiative and respected neurologist, is yes. Learn more about this and issues like it at www.houstonhealthcareinitiative.org.
Nov 3, 2020
There are currently 120 Coronavirus/Covid-19 vaccines in development and a race to be the first one available for the public. Being first with this vaccine will mean big rewards for the maker in the form of profits and scientific prestige. Along with these developments there is political pressure to not only be first but be first by election day. Regardless, the benefits of a vaccine for this extremely contagious virus will ultimately accrue to the public. But nothing is foolproof and there will be problems with this vaccine because there were with all of them. And when there are problems who is ultimately responsible and how can the public find justice? To know better what the possible risk benefit for a vaccine to the Covid-19 is and help us understand the possible downside and upside is respected Houston neurologist Dr. Steven Goldstein.
Oct 12, 2020
A group of U.S. doctors known collectively as the Association of American Physicians and Surgeons or the AAPS recently sued the Food and Drug Administration (FDA) for limiting use of hydroxychloroquine, and the right to prescribe hydroxychloroquine as an off-label treatment for the Coronavirus/Covid-19 virus. But there is a larger issue here that will eventually transcend the Coronavirus/Covid-19 pandemic and that is who ultimately decides what medicines we can take? Who is it that has more or less influence than they should?
Sep 28, 2020
On this edition we have a guest, Mr. Gerald Posner. Mr. Posner is an accomplished investigative journalist and the author of a dozen books including “Case Closed,” a re-examination of the assassination of John F. Kennedy, and “Mengele,” an account of the botched hunt for the Nazi war criminal. His latest work is “Pharma: Greed, Lies, and the Poisoning of America.” This book describes something we here are all very interest in which is the history of the pharmaceutical manufacturing industry. I was shocked to read that many of the practices that were incorporated into marketing and selling heroin and cocaine in the early 20th century are still used today. And like they did before, the same companies are deliberately downplaying of the risk of modern-day medicines like opioids that have led to addiction and death for so many Americans. This along with an emphasis on profits over patient well-being are included.
Sep 14, 2020
On August 23, 2020 the Food and Drug Administration’s announced a decision to grant blood plasma treatment for Coronavirus/Covid-19 patients with a fast-track authorization for its emergency use as a treatment for hospitalized COVID patients. This “emergency use authorization” triggered an outcry from scientists and doctors, who said the decision was not supported by adequate clinical evidence and criticized the FDA for what was perceived as bowing to political pressure. News coverage about this potential treatment has done little to clarify whether its useful or not. The idea that there could be a motivation behind the fast track authorization for this potential treatment other than looking for a useful therapeutic is troubling. More to the point, who should decide what patients receive in treatment for their illnesses? To help us make sense of how reforms for the pharmaceutical industry could potentially help separate facts from spin and who we should all listen to is respected neurologist, Dr. Steven Goldstein.
Sep 8, 2020
Early in the pandemic, hydroxychloroquine looked like it could be a promising treatment for COVID-19 but use of the drug quickly lost favor after articles in the Lancet and New England Journal of Medicine cast doubt. Both journals retracted the articles but the damage was done. Listen to Dr. Steven Goldstein describe how and why this went wrong.
Aug 23, 2020